A Pilot Study for Pharmacokinetic/Pharmacodynamic (PK/PD) Parameter of Allopurinol and Its Metabolite-oxypurinol After Once-daily Allopurinol in Chronic Kidney Disease Patient
After the result of this pilot study, we can prescribe the optimal dose of allopurinol in CKD patient.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
from 18yrs to 80yrs , man and women
the patient who are taking allopurinol
On screening, the patient shows that the level of protein/creatinine ratio is over 3.0
On screening, the patient shows that MDRD GFR \>= 30 ml/min and \<= 60 ml/min
the patient sign on the concent form
You may not be if
the patient have experience to take medication that have an effect on renal function
the patient have experience to take cyclosporin within 3month
At least, the average level of two separate blood pressure ( 2min interval ) shows that SBP \<= 100 mmHg or \>=160 mmHg and DBP \<=60 mmHg \>=100 mmHg, or Heart rate \< 40 beats/min or \> 90 beats/min
uncontrolled hypertension
pregnancy or anticipate pregnancy with 6 month
hypersensitivity to allopurinol
acute hepatitis or the level of AST or ALT is over 2times of normal range or the level of bilirubin is over 2.0 mg/dL
serum albumin \< 3.5 mg/dL or \> 5mg/dL
urinary retension, prostatic hyperplasia
the patient show gout attack on taking allopurinol
the patient who have gastro-intestinal disease ( ex, crohn's disease, acute or chronic pancreatitis, ulcer )or who have the surgical history of gastrointestine.
the patient who should take azathioprine, mercaptopurine, cyclophosphamide, Losartan, benzbromarone,fenofibrate,furosemide ,probenecid
the patient who had taken part in the other study within 3months
